Olympus Therapeutics Private Limited, a active private limited company, was established on 24 June 2015 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24290TN2015PTC101114. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹9.90 M and a paid-up capital of ₹7.39 M.
It upholds a compliant status. Employing 128 professional, Its leadership includes Ravichandran Venkatraman (Director), Krishnamurthymani (Director). Past directors included Venkataraghavan Sourirajan, Karnnanidhi Venneela Ramanar, Sekaripuram Anantaraman Manikandan. It holds ₹2.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.31, Balaji Nagar 5Th Cross Street, Ekkatuthangal,, Chennai, Tamil Nadu, 600032.
U24290TN2015PTC101114
101114
24 June 2015
₹9.90 M
₹7.39 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Olympus Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravichandran Venkatraman | Director | 20 Mar 2025 | Current |
| Krishnamurthymani | Director | 20 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Feb 2023 | Past |
| Pramod Abcsdd | Director | 20 Mar 2025 | Past |
| Pramod Abcsdd | Additional Director | 19 Aug 2019 | Past |
| Pramod Abcsdd | Additional Director | 29 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Olympus Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.17% increase. The company also saw a substantial improvement in profitability, with a 10.89% increase in profit. The company's net worth Soared by an impressive increase of 12.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Olympus Therapeutics had a public holding of 35.61%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹20,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Feb 2024 | Others | ₹1.00 Cr | Open |
| 14 Jun 2023 | Hdfc Bank Limited | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Olympus Therapeutics has a workforce of 128 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Olympus Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Olympus Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ravichandran Venkatraman was appointed as a Director was appointed as a Director on 20 Mar 2025 & has been associated with this company since 8 months 11 days . was documented.
Progress on Krishnamurthymani was appointed as a Director was appointed as a Director on 20 Mar 2025 & has been associated with this company since 8 months 11 days . was documented.
Olympus Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Olympus Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
The activity A charge with Others amounted to Rs. 10.00 M with Charge ID 100890048 was registered on 02 Feb 2024. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 10.00 M with Charge ID 100789207 was registered on 14 Jun 2023. was documented.
The CIN of Olympus Therapeutics Private Limited is U24290TN2015PTC101114.
Olympus Therapeutics Private Limited is headquartered at No.31, Balaji Nagar 5Th Cross Street, Ekkatuthangal,, Chennai, Tamil Nadu, 600032.
Olympus Therapeutics Private Limited was incorporated on 24 June 2015.
The current directors of Olympus Therapeutics Private Limited are
The primary industry of Olympus Therapeutics Private Limited is Trade.
Olympus Therapeutics Private Limited is unlisted.
The authorized capital of Olympus Therapeutics Private Limited is ₹9.90 M, and the paid-up capital is ₹7.39 M.
The compliance status of Olympus Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX